An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis

Nature Genetics

Volumn 37, Issue 1, 2005, Pages 48-55

  Sweet Cordero, Alejandro ^a   Mukherjee, Sayan ^c,d   Subramanian, Aravind ^c   You, Han ^a   Roix, Jeffrey J ^a   Ladd Acosta, Christine ^c   Mesirov, Jill ^c   Golub, Todd R ^b   Jacks, Tyler ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS 2 PROTEIN; K RAS PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; MODEL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE K RAS; ONCOGENE K RAS 2; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; GENE EXPRESSION; GENE EXPRESSION PROFILING; LUNG NEOPLASMS; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY;

ANIMALIA;

EID: 11244258643     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1490     Document Type: Article

References (36)

1. van't Veer, L.J. et al. Expression profiling predicts outcome in breast cancer. Breast Cancer Res 5, 57-58(2002).
2. Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (2003).
3. Chang, H.Y. et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2, E7 (2004).
4. Armstrong, S.A. et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30, 41-47 (2002).
5. Ferrando, A.A. et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87 (2002).
6. Ross, M.E. et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102, 2951-2959 (2003).
7. Desai, K.V. et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc. Natl. Acad. Sci. USA 99, 6967-6972 (2002).
8. Huang, E. et al. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat. Genet. 34, 226-230 (2003).
9. Tuveson, D.A. et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375-387 (2004).
10. Repasky, G.A., Chenette, E.J. & Der, C.J. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol. 14, 639-647 (2004).
11. Zuber, J. et al. A genome-wide survey of RAS transformation targets. Nat. Genet. 24, 144-152 (2000).
12. Tchernitsa, O.I. et al. Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 23, 4536-4555 (2004).
13. Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
14. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
15. Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci USA 98, 13790-13795 (2001).
16. Vapnik, V.N. Statistical Learning Theory (John Wiley and Sons, New York, 1998).
17. Ramaswamy, S. et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 98, 15149-15154 (2001).
18. Lamb, J. et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323-334 (2003).
19. Mootha, V.K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
20. Bonner, A.E., Lemon, W.J., Devereux, T.R., Lubet, R.A. & You, M. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene 23, 1166-1176 (2004).
21. Lo, R.S., Wotton, D. & Massague, J. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J. 20, 128-136 (2001).
22. Beer, D.G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8, 816-824 (2002).
23. Naoki, K., Chen, T.H., Richards, W.G., Sugarbaker, D.J. & Meyerson, M. Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res. 62, 7001-7003 (2002).
24. Paez, J.G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497-1500 (2004).
25. Iacobuzio-Donahue, C.A. et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162, 1151-1162 (2003).
26. Klimstra, D.S. & Longnecker, D.S. K-ras mutations in pancreatic ductal proliferative lesions. Am. J. Pathol. 145, 1547-1550 (1994).
27. Peeper, D.S. et al. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386, 177-181 (1997).
28. Camps, M. et al. Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS Lett. 425, 271-276 (1998).
29. Muda, M. et al. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271, 27205-27208 (1996).
30. Kawakami, Y. et al. MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat. Cell Biol. 5, 513-519 (2003).
31. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
32. Toyoshima, Y. et al. TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival. J. Biol. Chem. 279, 25898-25904 (2004).
33. Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223-238 (2003).
34. Golub, T.R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
35. Rubinson, D.A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406 (2003).
36. Mantel, N. The detection of disease clustering and a generalized regression approach 27, 209-220 (1967).